Product Information
TRETINOIN 10 MG CAPSULE is a generic product labeled by Endo USA Inc., priced at $8.5310 per EA under NDC 10370026801. Its NADAC has been published 111 times since Jan 22, 2014.
FDA first approved this application on Oct 24, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Endo USA Inc.NDC
10370026801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA201687FDA Approved
10/24/2012
TE Code
AB
On Market Since
10/24/2012
Pharmacological Classes
Price Statistics
The NADAC for TRETINOIN 10 MG CAPSULE has been published 111 times since Jan 22, 2014, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.5310 per EA |
|---|---|
| All-time high | $21.1886 (Feb 11, 2015) |
| All-time low | $8.5310 (Aug 19, 2026) |
| 52-week high | $12.4863 |
| 52-week low | $8.5310 |
| Median price | $21.1886 |
| Average price | $15.8516 |
| Largest weekly change | -41.1% (Sep 17, 2025) |
| Weeks tracked | 111 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRETINOIN 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TRETINOIN 10 MG CAPSULE, manufactured by Endo USA Inc., is $8.5310 per EA (NDC 10370026801), effective Sep 30, 2026.
How has the price of TRETINOIN 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TRETINOIN 10 MG CAPSULE has declined 59.7%. It has been tracked across 111 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for TRETINOIN 10 MG CAPSULE?
Since Jan 22, 2014, the NADAC for TRETINOIN 10 MG CAPSULE has ranged from a low of $8.5310 (Aug 19, 2026) to a high of $21.1886 (Feb 11, 2015), with a median of $21.1886 per EA.
Are there cheaper alternatives to TRETINOIN 10 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRETINOIN 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TRETINOIN 10 MG CAPSULE?
TRETINOIN 10 MG CAPSULE (NDC 10370026801) is labeled by Endo USA Inc., and CMS classifies it as a generic product.